Ketamine therapy for mental health gains popularity, but lacks regulation, as a study on veterans reveals mixed results and raises concerns among experts.

The ketamine economy, offering infusions for mental health issues, has witnessed a surge in for-profit clinics and revenues reaching $3.1 billion in 2022, projected to double to $6.9 billion by 2030. Despite the lack of FDA approval for mental health treatment, the drug has become increasingly common in the US due to the desperate need for effective solutions for conditions such as depression. Ketamine's off-label use and the variability in treatment protocols, ranging from low-dosage to hallucination-inducing amounts, raise concerns about its safety and regulation.

February 01, 2024
12 Articles

Further Reading